BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37554550)

  • 1. Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model.
    Passier M; van Genderen MNG; Zaalberg A; Kneppers J; Bekers EM; Bergman AM; Zwart W; Eduati F
    Cancer Res Commun; 2023 Aug; 3(8):1473-1485. PubMed ID: 37554550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.
    Pereira BA; Lister NL; Hashimoto K; Teng L; Flandes-Iparraguirre M; Eder A; Sanchez-Herrero A; Niranjan B;
    Biomaterials; 2019 Mar; 197():72-85. PubMed ID: 30641266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment.
    Vickman RE; Broman MM; Lanman NA; Franco OE; Sudyanti PAG; Ni Y; Ji Y; Helfand BT; Petkewicz J; Paterakos MC; Crawford SE; Ratliff TL; Hayward SW
    Prostate; 2020 Feb; 80(2):173-185. PubMed ID: 31763714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs).
    Clark KC; Wu Y; Taylor RA; Daly RJ
    Crit Rev Oncog; 2022; 27(1):1-24. PubMed ID: 35993976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
    Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
    Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF).
    Vancauwenberghe E; Noyer L; Derouiche S; Lemonnier L; Gosset P; Sadofsky LR; Mariot P; Warnier M; Bokhobza A; Slomianny C; Mauroy B; Bonnal JL; Dewailly E; Delcourt P; Allart L; Desruelles E; Prevarskaya N; Roudbaraki M
    Mol Carcinog; 2017 Aug; 56(8):1851-1867. PubMed ID: 28277613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.
    Kryza T; Silva LM; Bock N; Fuhrman-Luck RA; Stephens CR; Gao J; Samaratunga H; ; Lawrence MG; Hooper JD; Dong Y; Risbridger GP; Clements JA
    Mol Oncol; 2017 Oct; 11(10):1307-1329. PubMed ID: 28510269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling.
    Qin H; Yang Y; Jiang B; Pan C; Chen W; Diao W; Ding M; Cao W; Zhang Z; Chen M; Gao J; Zhao X; Qiu X; Guo H
    FEBS J; 2021 Sep; 288(18):5406-5429. PubMed ID: 33705609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and Function of a Prostate Cancer Dissemination-Permissive Extracellular Matrix.
    Penet MF; Kakkad S; Pathak AP; Krishnamachary B; Mironchik Y; Raman V; Solaiyappan M; Bhujwalla ZM
    Clin Cancer Res; 2017 May; 23(9):2245-2254. PubMed ID: 27799248
    [No Abstract]   [Full Text] [Related]  

  • 11. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.
    Ting HJ; Deep G; Jain AK; Cimic A; Sirintrapun J; Romero LM; Cramer SD; Agarwal C; Agarwal R
    Mol Carcinog; 2015 Sep; 54(9):730-41. PubMed ID: 24615813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
    Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells and microenvironment in prostate cancer progression.
    Liao CP; Adisetiyo H; Liang M; Roy-Burman P
    Horm Cancer; 2010 Dec; 1(6):297-305. PubMed ID: 21761361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model.
    Linxweiler J; Hajili T; Körbel C; Berchem C; Zeuschner P; Müller A; Stöckle M; Menger MD; Junker K; Saar M
    Sci Rep; 2020 Jul; 10(1):12575. PubMed ID: 32724081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death.
    Cheteh EH; Augsten M; Rundqvist H; Bianchi J; Sarne V; Egevad L; Bykov VJ; Östman A; Wiman KG
    Cell Death Dis; 2017 Jun; 8(6):e2848. PubMed ID: 28569790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1.
    Barcellos-de-Souza P; Comito G; Pons-Segura C; Taddei ML; Gori V; Becherucci V; Bambi F; Margheri F; Laurenzana A; Del Rosso M; Chiarugi P
    Stem Cells; 2016 Oct; 34(10):2536-2547. PubMed ID: 27300750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating tumor reactive stroma by extracorporeal shock waves to control prostate cancer progression.
    Rinella L; Pizzo B; Frairia R; Delsedime L; Calleris G; Gontero P; Zunino V; Fortunati N; Arvat E; Catalano MG
    Prostate; 2020 Sep; 80(13):1087-1096. PubMed ID: 32609927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line.
    Kaur SP; Verma A; Lee HK; Barnett LM; Somanath PR; Cummings BS
    Sci Rep; 2021 Apr; 11(1):9262. PubMed ID: 33927256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.